UK Validation of the Automated "AcceXible" Speech Analysis Software
NCT: NCT05534958 · COMPLETED
Brief Summary
Dementia, especially dementia caused by Alzheimer's disease, is considered one of the most severe health problems of our time. It is currently known that the disease begins many years before clinical symptoms appear. The sooner the patient is diagnosed, the sooner the patient will be in a position to prevent further deterioration. A recent orientation is the analysis of language in relation to the description of images with a high and varied semantic and emotional content. It can be studied that changes in the description of an image check if these changes are associated with the evolution of a person with probable impairment both in memory and cognitive as well as emotional, psychiatric, behavioral and even in their interaction with environmental factors especially those associated with socialization and loneliness. The present study has the objective of validating a digital method for detection and follow-up of patients with mild cognitive impairment (MCI) or dementia in a memory clinic setting.
Frequently Asked Questions
What is UK Validation of the Automated "AcceXible" Speech Analysis Software?
UK Validation of the Automated "AcceXible" Speech Analysis Software is a clinical trial registered under NCT05534958. Current status: COMPLETED.
What is the status of NCT05534958?
The current status of NCT05534958 (UK Validation of the Automated "AcceXible" Speech Analysis Software) is: COMPLETED.
When did UK Validation of the Automated "AcceXible" Speech Analysis Software start?
UK Validation of the Automated "AcceXible" Speech Analysis Software started on 2022-11-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.